Loading...
Disclaimer: Informational only β not medical advice. AI hypotheses are not clinically validated. Medic Oath is for informational and educational purposes only β not medical advice. AI-generated hypotheses have not been clinically validated. Always consult a qualified healthcare professional. Privacy Β· Terms
A rare disorder that disrupts the synthesis of estradiol, resulting in hirsutism of mothers during gestation of an affected child; pseudohermaphroditism and virilization in women; and tall stature, osteoporosis and obesity in men.
Raloxifene acts as SERM providing bone protection while allowing low-dose estradiol to maintain reproductive and metabolic functions, optimizing ESR1/ESR2 signaling while minimizing adverse effects
Development of GPR30 (GPER1)-selective agonists to activate rapid estrogen signaling pathways independently of classical nuclear receptors, bypassing the need for aromatase-dependent estrogen synthesis
Puerarin and miroestrol from Pueraria mirifica act as selective estrogen receptor modulators (SERMs), binding to ERΞ± and ERΞ² receptors to compensate for reduced endogenous estradiol production due to CYP19A1 deficiency
Unkei-to components enhance alternative estrogen synthesis pathways through upregulation of HSD17B1 and CYP1A1, while genistein and daidzein provide direct phytoestrogenic activity to compensate for CYP19A1 deficiency
Saponins including shatavarin I-IV modulate hypothalamic-pituitary-gonadal axis through effects on GnRH, LH, and FSH regulation, while providing mild phytoestrogenic activity through steroid receptor binding
CRISPR-based cytosine or adenine base editors target specific point mutations in CYP19A1 gene, converting pathogenic variants to wild-type sequence without creating double-strand breaks